UPDATE -- ResMed Unveils New Collection of Digital and Personalized Solutions designed to Improve Sleep Health
30 sept. 2024 09h48 HE
|
ResMed Inc.
ResMed Unveils New Collection of Digital and Personalized Solutions designed to
Improve Sleep Health
UPDATE -- ResMed Enhances CPAP Therapy with its First Fabric Mask, Designed to Make it Easier for People to Embrace Their Treatment and Improve Overall Sleep Health
30 sept. 2024 09h23 HE
|
ResMed Inc.
ResMed Enhances CPAP Therapy with its First Fabric Mask, Designed to Make it Easier for People to Embrace Their Treatment and Improve Overall Sleep Health
ResMed Enhances CPAP Therapy with its First Fabric Mask, Designed to Make it Easier for People to Embrace Their Treatment and Improve Overall Sleep Health
30 sept. 2024 08h10 HE
|
ResMed Inc.
ResMed Enhances CPAP Therapy with its First Fabric Mask, Designed to Make it Easier for People to Embrace Their Treatment and Improve Overall Sleep Health
ResMed Unveils New Collection of Digital and Personalized Solutions designed to Improve Sleep Health
30 sept. 2024 08h01 HE
|
ResMed Inc.
ResMed Unveils New Collection of Digital and Personalized Solutions designed to
Improve Sleep Health
Vaping Expected to Increase COPD Health and Economic Burden by 2050
10 sept. 2024 08h00 HE
|
ResMed Inc.
Vaping Expected to Increase COPD Health and Economic Burden by 2050
New ResMed-supported research presented at ERS 2024
External Nasal Dilator Market to Reach $162.4 Million, Globally, by 2033 at 5.1% CAGR: Allied Market Research
16 août 2024 10h14 HE
|
Allied Analytics LLP
Wilmington, Delaware, Aug. 16, 2024 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, "External Nasal Dilator Market by Application (Snoring, Sleep apnea, Nasal congestion and...
PAP Therapy Reduces Hospitalizations by 31% and ER Visits by 23% for People with Obstructive Sleep Apnea and Comorbid Insomnia
10 juin 2024 09h05 HE
|
ResMed Inc.
ResMed-supported research presented at SLEEP2024 demonstrates the effectiveness and value of positive airway pressure (PAP) treatment for OSA.
Apnimed Announces a Robust Slate of Presentations at SLEEP 2024, Including an Analysis of the Prevalence of Obesity in Obstructive Sleep Apnea
23 mai 2024 09h50 HE
|
Apnimed, Inc.
Apnimed Announces a Robust Slate of Presentations at SLEEP 2024, Including an Analysis of the Prevalence of Obesity in Obstructive Sleep Apnea
ProSomnus Contributes Two Scientific Abstracts Accepted for Presentation at the 2024 American Academy of Dental Sleep Medicine Annual Meeting
13 mai 2024 09h00 HE
|
ProSomnus Sleep Technologies, Inc.
ProSomnus Contributes Two Scientific Abstracts Accepted for Presentation at the 2024 American Academy of Dental Sleep Medicine Annual Meeting
Four Independent Scientific Abstracts at the American Academy of Dental Sleep Medicine Annual Meeting Feature ProSomnus Intraoral Medical Devices
09 mai 2024 18h30 HE
|
ProSomnus Sleep Technologies, Inc.
Four Independent Scientific Abstracts at the American Academy of Dental Sleep Medicine Annual Meeting Feature ProSomnus Intraoral Medical Devices